Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAIN-1: Gemcitabine and Abraxane in Pancreatic Cancer
NCT01470417Phase 2Completed
- Sponsor
- University of Florida
- Start
- Oct 2011
- Primary completion
- Jan 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in pancreatic adenocarcinoma (PDAC), sponsored by University of Florida. Started Oct 2011; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01470417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470417.